Cargando…
Uncarboxylated osteocalcin alleviates the inhibitory effect of high glucose on osteogenic differentiation of mouse bone marrow–derived mesenchymal stem cells by regulating TP63
BACKGROUND: Progressive population aging has contributed to the increased global prevalence of diabetes and osteoporosis. Inhibition of osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) by hyperglycemia is a potential pathogenetic mechanism of osteoporosis in diabetic patients...
Autores principales: | Gong, Fangzi, Gao, Le, Ma, Luyao, Li, Guangxin, Yang, Jianhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080387/ https://www.ncbi.nlm.nih.gov/pubmed/33906607 http://dx.doi.org/10.1186/s12860-021-00365-7 |
Ejemplares similares
-
Uncarboxylated Osteocalcin Decreases SCD1 by Activating AMPK to Alleviate Hepatocyte Lipid Accumulation
por: Wang, Danqing, et al.
Publicado: (2023) -
Smoking cessation increases levels of osteocalcin and uncarboxylated osteocalcin in human sera
por: Kiyota, Yasuhiro, et al.
Publicado: (2020) -
Uncarboxylated osteocalcin promotes proliferation and metastasis of MDA-MB-231 cells through TGF-β/SMAD3 signaling pathway
por: Xu, Jiaojiao, et al.
Publicado: (2022) -
Differential Roles of Carboxylated and Uncarboxylated Osteocalcin in Prostate Cancer Growth
por: Hayashi, Yoshikazu, et al.
Publicado: (2016) -
Assessment of Uncarboxylated Osteocalcin Levels in Type 2 Diabetes Mellitus
por: Alamri, Taghreed M, et al.
Publicado: (2023)